Letrozole and Trimethoprim drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Letrozole (letrozole) and Trimethoprim (trimethoprim). Common drug interactions include diarrhoea among females.
The phase IV clinical study analyzes what interactions people have when they take Letrozole and Trimethoprim. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.
What is Letrozole?
Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 54,125 Letrozole users. Check the latest studies of Letrozole.
What is Trimethoprim?
Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 8,213 Trimethoprim users. Check the latest studies of Trimethoprim.
89 people who take Letrozole and Trimethoprim together, and have interactions are studied.

What are the common drug interactions of Letrozole and Trimethoprim, by gender? *:
female:
- Diarrhoea
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Rash pruritic (redness with itching)
- Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
- Death
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Asthenia (weakness)
- Cellulitis (infection under the skin)
male:
n/a
What are the common drug interactions of Letrozole and Trimethoprim, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Hydronephrosis (water inside the kidney)
- Insomnia (sleeplessness)
- Neuropathy peripheral (surface nerve damage)
- Conjunctivitis (pink eye)
- Nausea (feeling of having an urge to vomit)
- Oral candidiasis (fungal infection of mouth)
- Rectal haemorrhage (bleeding from anus)
- Vulvovaginal candidiasis (vulvovaginal infection by fungi)
- Abnormal sensation in eye
- Asthenia (weakness)
50-59:
- Cellulitis (infection under the skin)
- Constipation
- Diarrhoea
- Escherichia infection (bacterial infection by escherichia coli)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Klebsiella infection
- Lower respiratory tract infection
- Pneumonia
- Pyrexia (fever)
- Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
- Diarrhoea
- Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
- Rash pruritic (redness with itching)
- Rectal haemorrhage (bleeding from anus)
- Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
- Death
- Headache (pain in head)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Pain in extremity
- Swelling face
What are the existing conditions these people have? *
- Breast Cancer Metastatic: 62 people, 69.66%
- High Blood Pressure: 31 people, 34.83%
- Cellulitis (infection under the skin): 29 people, 32.58%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 26 people, 29.21%
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 25 people, 28.09%
- Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 25 people, 28.09%
- Back Pain: 25 people, 28.09%
- Blood Phosphorus Decreased: 25 people, 28.09%
- Blood Potassium Decreased: 25 people, 28.09%
- Gastrointestinal Motility Disorder (abnormal intestinal contractions): 25 people, 28.09%
* Approximation only. Some reports may have incomplete information.
Do you take Letrozole and Trimethoprim?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Letrozole (54,125 reports)
- Trimethoprim (8,213 reports)
Browse all drug interactions of Letrozole and Trimethoprim:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Letrozole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Trimethoprim:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Letrozole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trimethoprim and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on letrozole and trimethoprim (the active ingredients of Letrozole and Trimethoprim, respectively), and Letrozole and Trimethoprim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cyanocobalamin cause Swelling Face? - 9 seconds ago
- Could Ganirelix Acetate cause Hot Flush? - 15 seconds ago
- Could Adderall cause Actinic Keratosis? - 22 seconds ago
- Drug interactions of Quetiapine Fumarate and Tryptophan - 26 seconds ago
- Drug interactions of Imdur and Klor-Con - 31 seconds ago
- Could Palbociclib cause Vitamin D Decreased? - 34 seconds ago
- Could Soolantra cause Dyspnea Exacerbated? - 34 seconds ago
- Abdominal Pain Aggravated and Acne - 34 seconds ago
- Could Sumatriptan cause Eye Movement Disorder? - 34 seconds ago
- Could Sumatriptan Succinate cause Nervous System Disorder? - 38 seconds ago